Division of Parasitic Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333, USA.
NTD Support Center, Task Force for Global Health, 325 Swanton Way, Decatur, GA 30030, USA.
Int Health. 2020 Dec 22;13(Suppl 1):S65-S70. doi: 10.1093/inthealth/ihaa084.
The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was established with the ambitious goal of eliminating LF as a public health problem. The remarkable success of the GPELF over the past 2 decades in carrying out its principal strategy of scaling up and scaling down mass drug administration has relied first on the development of a rigorous monitoring and evaluation (M&E) framework and then the willingness of the World Health Organization and its community of partners to modify this framework in response to the practical experiences of national programmes. This flexibility was facilitated by the strong partnership that developed among researchers, LF programme managers and donors willing to support the necessary research agenda. This brief review summarizes the historical evolution of the GPELF M&E strategies and highlights current research needed to achieve the elimination goal.
全球消灭淋巴丝虫病规划(GPELF)的目标是消除淋巴丝虫病这一公共卫生问题。在过去的 20 年里,GPELF 取得了显著的成功,其主要策略是扩大和缩小大规模药物治疗的规模,这首先依赖于制定一个严格的监测和评价(M&E)框架,然后是世界卫生组织及其合作伙伴社区愿意根据国家规划的实际经验修改这一框架。这种灵活性得益于研究人员、淋巴丝虫病规划管理人员和愿意支持必要研究议程的捐助者之间建立的强有力伙伴关系。本简要回顾总结了 GPELF 监测和评价策略的历史演变,并强调了实现消除目标所需的当前研究。